The Oncology Institute Appoints Kim Tzoumakas to Board of Directors
The Oncology Institute, Inc. (TOI)
Company Research
Source: GlobeNewswire
CERRITOS, Calif., Feb. 23, 2026 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (“TOI”) (NASDAQ: TOI), one of the largest value-based oncology groups in the United States, today announced the appointment of Kim Tzoumakas to its Board of Directors, effective February 23, 2026. Ms. Tzoumakas brings more than two decades of executive leadership experience across oncology, pharmacy services and healthcare operations. Notably, she is Chief Executive Officer for VytlOne National Pharmacy Services, and previously held the CEO role at 21st Century Oncology, where she successfully led the organization through a multi-year operational turnaround, culminating in its strategic sale. She also has served on the board of several private and public healthcare companies including SeaSpine, Coherus BioSciences, Ob Hospitalist Group and most recently, VytlOne. “We are thrilled to welcome Kim to our Board of Directors,” said Daniel Virnich, MD, CEO of The Oncology Institute. “Her deep experience in b
Show less
Read more
Impact Snapshot
Event Time:
TOI
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TOI alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TOI alerts
High impacting The Oncology Institute, Inc. news events
Weekly update
A roundup of the hottest topics
TOI
News
- The Oncology Institute Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference CallGlobeNewswire
- The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in March [Yahoo! Finance]Yahoo! Finance
- The Oncology Institute to Participate in Multiple Healthcare Investor Conferences in MarchGlobeNewswire
- The Oncology Institute Reaffirms 2025 Guidance and Provides Preliminary 2026 OutlookGlobeNewswire
- U.S. Neurology Associates Partners with M33 Growth to Transform Neurological CareGlobeNewswire
TOI
Earnings
- 11/13/25 - Miss
TOI
Sec Filings
- 2/23/26 - Form 8-K
- 1/15/26 - Form SCHEDULE
- 1/12/26 - Form 3
- TOI's page on the SEC website